How many clinical trials are there for Esophagus Adenocarcinoma?

PlainTrial tracks 1 US clinical trials for Esophagus Adenocarcinoma, of which 1 are currently recruiting.

Which interventions appear most often on Esophagus Adenocarcinoma trial records?

Itraconazole is the most-linked intervention name on Esophagus Adenocarcinoma records (1 trial links). Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Esophagus Adenocarcinoma?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Esophagus Adenocarcinoma: early-phase trial registry

Compiled by PlainTrial · August 8, 2026

1 of 1 indexed Esophagus Adenocarcinoma trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Esophagus Adenocarcinoma: 1 US clinical trial tracked, 1 recruiting.

Esophagus Adenocarcinoma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dallas VA Medical Center, running 1 of these trials.

Enrollment posture brief

Registry condition esophagus-adenocarcinoma

Volume-matched condition peers

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Open-enrollment share among volume-matched conditions near Esophagus Adenocarcinoma

Esophagus Adenocarcinoma lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Esophagus Adenocarcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Esophagus Adenocarcinoma is recruiting above its size-band peers.

1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

1 total, page 1 of 1

RECRUITING Phase 2 78 participants

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Dallas VA Medical Center

NCT04018872

Phase Distribution

Phase	Trial count
Phase 2	1

Top Sponsors

Dallas VA Medical Center 1 trials

Named interventions

Most-linked intervention names on Esophagus Adenocarcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Itraconazole Drug

1 trials

US sites by state

Facility locations filed on Esophagus Adenocarcinoma trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Esophagus Adenocarcinoma page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

1 Esophagus Adenocarcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
Dallas VA Medical Center sponsors the most Esophagus Adenocarcinoma trials on record, review their full trial history before evaluating a specific study. See Dallas VA Medical Center's trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Esophagus Adenocarcinoma condition card totals 1 registered trials; most-linked intervention Itraconazole; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.